Increased cholinergic activity under conditions of low estrogen leads to adverse cardiac remodeling

Cholinesterase inhibitors are used in postmenopausal women for the treatment of neurodegenerative diseases. Despite their widespread use in the clinical practice, little is known about the impact o...